Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
26 nov. 2024 16h05 HE
|
Lifecore Biomedical, Inc.
Three-Year Term Extension Combined with Simplification and Reduction of Interest Rates Helps Further Strengthen Company’s Balance Sheet and Overall Financial Position Builds Upon Other Recent...
Lifecore Biomedical Hosts Virtual Investor Day
21 nov. 2024 16h17 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical to Present at Stephens Annual Investment Conference
12 nov. 2024 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
07 nov. 2024 07h00 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
04 nov. 2024 07h00 HE
|
Lifecore Biomedical, Inc.
Brings Strong Background in Pharmaceutical Manufacturing Operations and Finance to Help Drive Performance and Productivity Jackie Klecker Named Executive Vice President, Quality and Development...
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
04 oct. 2024 07h30 HE
|
Lifecore Biomedical, Inc.
-- Recorded Revenues of $24.7 Million for Q1 Fiscal 2025 ---- Signed Multiple New Business Agreements with New and Existing Customers ---- More than Doubled Capacity with Installation of 5-Head...
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
04 oct. 2024 07h20 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the closing...
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
03 oct. 2024 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
01 oct. 2024 07h00 HE
|
Lifecore Biomedical, Inc.
Multi-Million Dollar Development Agreement Establishes Lifecore as Lindy Biosciences’ Preferred CDMO Offers Lifecore Key Access Point into Manufacture and Fill/Finish of Next-Generation...
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
25 sept. 2024 16h05 HE
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...